AngioDynamics (ANGO) Tops Q1 EPS by 2c, Updates Guidance

AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $77 million versus the consensus estimate of $71.31 million.

GUIDANCE:

AngioDynamics sees FY2022 EPS of $0.00-$0.05, versus the consensus of $0.04. AngioDynamics sees FY2022 revenue of $310-315 million, versus the consensus of $307.8 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• KT&G approves KRW 360 billion share buyback and retirement plan
• UBS Reiterates Buy Rating on Option Care Health (OPCH) Following Check-in Call Ahead of Quiet Period